Pharmaceutical

FDA approves Astellas’ VYLOY for gastric cancer treatment

Astellas Pharma has received approval from the FDA for VYLOY in conjunction with chemotherapy, for the treatment of advanced gastric cancer.

Oct 22, 2024 - 04:00
FDA approves Astellas’ VYLOY for gastric cancer treatment
Astellas Pharma has received approval from the FDA for VYLOY in conjunction with chemotherapy, for the treatment of advanced gastric cancer.
Read the original article

Tags:

Previous Article

FDA clamps partial hold on Phase III trial of BioNTech & OncoC4’s NSCLC therapy

Next Article

Novartis strikes $1.1B deal with China’s Baiyu for a small molecule cancer conte...

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Biden’s NIH nominee is languishing in Congress — alarming public health advocates

Biden’s NIH nominee is languishing in Congress — alarmi...

Jul 10, 2023

STAT+: House panel passes public health bills following contentious debate

STAT+: House panel passes public health bills following...

Jul 14, 2023

Social media risks for youth mental health highlighted in new surgeon general report

Social media risks for youth mental health highlighted ...

May 23, 2023